journal article·2018-12-12

Hydrophobicity-Adaptive Nanogels for Programmed Anticancer Drug Delivery

Hao Yang, Qin Wang, Zifu Li, Fuying Li, Di Wu, Man Fan, Anbi Zheng, Bo Huang, Lu Gan, Yuliang Zhao, Xiangliang Yang

Nano Letters· Volume 18· Issue 12
Publisher page

Abstract

Reconciling the conflicting needs for a prolonged circulation time, enhanced cellular uptake by bulk tumor cells and cancer stem cells (CSCs), and extensive tumor tissue penetration remains a major challenge for current nano drug delivery systems. Here we describe smart poly( N-isopropylacrylamide)-based nanogels with a fast adaptive hydrophobicity to solve these contradictory requirements for enhanced cancer chemotherapy. The nanogels are hydrophilic in the blood to prolong their circulation time. Once they accumulate at tumor sites, they rapidly become hydrophobic in response to tumor extracellular acidity. The adaptive hydrophobicity of the nanogels facilitates tumor accumulation, deep tumor penetration, and efficient uptake by bulk tumor cells and CSCs, resulting in a greater in vivo enrichment in tumor cells and side population cells. Together with lysosomal pH-regulated charge reversal and redox-responsive intracellular drug release, the nanogels escape from lysosomes and release their cargo doxorubicin. Thus, the nanogels significantly improve the in vivo anticancer efficacy and decrease side effects of doxorubicin. Strikingly, the ratio of CSCs is greatly decreased after treatment with the nanogels loaded with doxorubicin. Our current study provides new insights into designing effective anticancer drug delivery systems.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Nanoparticle-Based Drug Delivery · Nanoplatforms for cancer theranostics · Cancer, Hypoxia, and Metabolism

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

National Engineering Research Center for Nanomedicine, College of Life Science and Technology, Huazhong University of Science and Technology, Wuhan 430074, China

Hubei Key Laboratory of Bioinorganic Chemistry and Materia Medica, School of Chemistry and Chemical Engineering, Huazhong University of Science and Technology, Wuhan 430074, China

National Key Laboratory of Medical Molecular Biology, Department of Immunology, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences, Beijing 100005, China

Department of Biochemistry & Molecular Biology, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430074, China

CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, National Center for Nanoscience and Technology of China, Beijing 100190, China

Funding

Ministry of Science and Technology of the People's Republic of China · National Natural Science Foundation of China

References (50)

Show source-provided references
1. 10.1038/nrc249910.1038/nrc2499 ↗
2. 10.1038/nrc359710.1038/nrc3597 ↗
3. 10.2174/156800904333298910.2174/1568009043332989 ↗
4. 10.1038/nnano.2007.38710.1038/nnano.2007.387 ↗
5. 10.1016/j.addr.2012.10.00210.1016/j.addr.2012.10.002 ↗
6. 10.1002/adma.20180121610.1002/adma.201801216 ↗
7. 10.1016/j.biomaterials.2017.10.03010.1016/j.biomaterials.2017.10.030 ↗
8. 10.1038/nmat379210.1038/nmat3792 ↗
9. 10.1021/acsnano.6b0129610.1021/acsnano.6b01296 ↗
10. 10.1021/ja406992w10.1021/ja406992w ↗
11. 10.1002/adma.20160273810.1002/adma.201602738 ↗
12. 10.1002/anie.20131122710.1002/anie.201311227 ↗
13. 10.1038/nmat377610.1038/nmat3776 ↗
14. 10.1073/pnas.152208011310.1073/pnas.1522080113 ↗
15. 10.1021/acsnano.7b0521410.1021/acsnano.7b05214 ↗
16. 10.1002/adfm.20170283410.1002/adfm.201702834 ↗
17. 10.1038/nrc189310.1038/nrc1893 ↗
18. 10.1146/annurev-chembioeng-061010-11430010.1146/annurev-chembioeng-061010-114300 ↗
19. 10.1016/j.jconrel.2013.09.01310.1016/j.jconrel.2013.09.013 ↗
20. 10.1016/j.biomaterials.2015.12.01410.1016/j.biomaterials.2015.12.014 ↗
21. 10.1016/j.semcdb.2005.03.00710.1016/j.semcdb.2005.03.007 ↗
22. 10.1016/j.ccr.2009.03.01810.1016/j.ccr.2009.03.018 ↗
23. 10.1021/acsnano.5b0201710.1021/acsnano.5b02017 ↗
24. 10.1038/nnano.2011.16610.1038/nnano.2011.166 ↗
25. 10.1073/pnas.141149911110.1073/pnas.1411499111 ↗
26. 10.1016/j.nantod.2016.04.00810.1016/j.nantod.2016.04.008 ↗
27. 10.1002/adma.20120229610.1002/adma.201202296 ↗
28. 10.1016/j.nano.2015.09.00610.1016/j.nano.2015.09.006 ↗
29. 10.1002/adhm.20150053710.1002/adhm.201500537 ↗
30. 10.1016/j.biomaterials.2015.07.04810.1016/j.biomaterials.2015.07.048 ↗
31. 10.1016/j.biomaterials.2013.05.07810.1016/j.biomaterials.2013.05.078 ↗
32. 10.1021/acs.molpharmaceut.5b0006810.1021/acs.molpharmaceut.5b00068 ↗
33. 10.1021/acsnano.6b0232610.1021/acsnano.6b02326 ↗
34. 10.1021/jacs.5b0960210.1021/jacs.5b09602 ↗
35. 10.1016/j.biomaterials.2011.02.04510.1016/j.biomaterials.2011.02.045 ↗
36. 10.1016/j.addr.2010.09.00110.1016/j.addr.2010.09.001 ↗
37. 10.1016/j.biomaterials.2016.02.03110.1016/j.biomaterials.2016.02.031 ↗
38. 10.1002/anie.20150950710.1002/anie.201509507 ↗
39. 10.1021/nn301159a10.1021/nn301159a ↗
40. 10.1021/ja01577a03010.1021/ja01577a030 ↗
41. 10.1039/C6CS00592F10.1039/C6CS00592F ↗
42. 10.1021/nn503491e10.1021/nn503491e ↗
43. 10.1021/la00087a04010.1021/la00087a040 ↗
44. 10.1016/S0001-8686(99)00023-810.1016/S0001-8686(99)00023-8 ↗
45. 10.1016/j.cocis.2008.03.00410.1016/j.cocis.2008.03.004 ↗
46. 10.1146/annurev-physchem-032511-14373510.1146/annurev-physchem-032511-143735 ↗
47. 10.1038/nmat336110.1038/nmat3361 ↗
48. 10.1038/cr.2016.5310.1038/cr.2016.53 ↗
49. 10.1038/nrc311010.1038/nrc3110 ↗
50. 10.1021/acsami.6b1112710.1021/acsami.6b11127 ↗